October 2, 2024
Advances in T1D Prediction: An Algorithm To Help Define When a Person May Develop T1D
Learn how a team led by Carla Greenbaum, MD, is using “fancy math” to better understand not only if a person will develop T1D, but when.
September 24, 2024
Second Annual BRI T1D Family Day
June 1, 2024, marked the second annual Benaroya Research Institute T1D Family Day.
September 24, 2024
Working Toward Cures
Did you know that if risk screening results show you are in the early stages of T1D, you may be eligible to participate in a type 1 diabetes prevention study?
July 3, 2024
Investigating a Little-Understood Cell in MS
Find out how Estelle Bettelli, PhD, and her team are examining guardian cells that may play a big role in MS.
July 3, 2024
Exploring the Exposome: What Role Does Where You Live and What You’re Exposed to Play in Autoimmunity?
Read about BRI’s effort, led by Cate Speake, PhD, and Jane Buckner, MD, to better understand the role environmental factors play in autoimmune disease.
July 3, 2024
Two Half-Marathons in Two Days on Two Coasts to Support BRI
Learn about the challenge Gretchen Schoenstein took on to raise funds and awareness for BRI.
July 3, 2024
BRI’s Innovation Fund Sparks New Discoveries
Learn about one of the first projects launched with this funding, where Eddie James, PhD, and Caroline Stephanie, PhD, are exploring a new approach to treat type 1 diabetes.
May 30, 2024
Passing on the Hope: What I Learned Running Two Half-Marathons on Two Coasts in Two Days
Gretchen reflects on her journey from Washington, D.C., to Portland, Oregon, as she ran back-to-back half-marathons to raise autoimmune disease awareness and support immune system disease research at BRI.
April 3, 2024
Two Teens, Two Clinical Trials, One Vision: Living Better With T1D
Hear from teenagers Clara and Gibson about their experience participating in research and why it's important to them.
April 2, 2024
Why a New Cancer Treatment Can Lead to Autoimmunity
Why do some people taking checkpoint inhibitors for cancer develop side effects that look like autoimmunity? And could these side effects actually be a sign that the treatment is working? Peter Linsley, PhD and Ty Bottorff, PhD, intend to find out.
